456 related articles for article (PubMed ID: 2935938)
1. Positron emission tomography imaging of regional cerebral glucose metabolism.
Alavi A; Dann R; Chawluk J; Alavi J; Kushner M; Reivich M
Semin Nucl Med; 1986 Jan; 16(1):2-34. PubMed ID: 2935938
[TBL] [Abstract][Full Text] [Related]
2. Imaging local brain function with emission computed tomography.
Kuhl DE
Radiology; 1984 Mar; 150(3):625-31. PubMed ID: 6607481
[TBL] [Abstract][Full Text] [Related]
3. Positron emission tomography: human brain function and biochemistry.
Phelps ME; Mazziotta JC
Science; 1985 May; 228(4701):799-809. PubMed ID: 2860723
[TBL] [Abstract][Full Text] [Related]
4. Imaging and epilepsy.
Duncan JS
Brain; 1997 Feb; 120 ( Pt 2)():339-77. PubMed ID: 9117380
[TBL] [Abstract][Full Text] [Related]
5. FDG-PET in healthy and epileptic Lagotto Romagnolo dogs and changes in brain glucose uptake with age.
Jokinen TS; Haaparanta-Solin M; Viitmaa R; Grönroos TJ; Johansson J; Bergamasco L; Snellman M; Metsähonkala L
Vet Radiol Ultrasound; 2014; 55(3):331-41. PubMed ID: 24354474
[TBL] [Abstract][Full Text] [Related]
6. Neuronuclear assessment of patients with epilepsy.
Goffin K; Dedeurwaerdere S; Van Laere K; Van Paesschen W
Semin Nucl Med; 2008 Jul; 38(4):227-39. PubMed ID: 18514079
[TBL] [Abstract][Full Text] [Related]
7. Use of positron emission tomography for presurgical localization of eloquent brain areas in children with seizures.
Duncan JD; Moss SD; Bandy DJ; Manwaring K; Kaplan AM; Reiman EM; Chen K; Lawson MA; Wodrich DL
Pediatr Neurosurg; 1997 Mar; 26(3):144-56. PubMed ID: 9419031
[TBL] [Abstract][Full Text] [Related]
8. Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET.
Piert M; Koeppe RA; Giordani B; Berent S; Kuhl DE
J Nucl Med; 1996 Feb; 37(2):201-8. PubMed ID: 8667045
[TBL] [Abstract][Full Text] [Related]
9. [18F-fluorodeoxyglucose positron emission tomography in Parkinson's disease].
Arahata Y; Kato T; Tadokoro M; Sobue G
Nihon Rinsho; 1997 Jan; 55(1):222-6. PubMed ID: 9014454
[TBL] [Abstract][Full Text] [Related]
10. Cerebral glucose and dopa metabolism in movement disorders.
Martin WR; Hayden MR
Can J Neurol Sci; 1987 Aug; 14(3 Suppl):448-51. PubMed ID: 2960430
[TBL] [Abstract][Full Text] [Related]
11. Effects of human aging on patterns of local cerebral glucose utilization determined by the [18F]fluorodeoxyglucose method.
Kuhl DE; Metter EJ; Riege WH; Phelps ME
J Cereb Blood Flow Metab; 1982; 2(2):163-71. PubMed ID: 6978885
[TBL] [Abstract][Full Text] [Related]
12. Patterns of cerebral glucose utilization in Parkinson's disease and Huntington's disease.
Kuhl DE; Metter EJ; Riege WH; Markham CH
Ann Neurol; 1984; 15 Suppl():S119-25. PubMed ID: 6234856
[TBL] [Abstract][Full Text] [Related]
13. Positron computed tomography for studies of myocardial and cerebral function.
Phelps ME; Schelbert HR; Mazziotta JC
Ann Intern Med; 1983 Mar; 98(3):339-59. PubMed ID: 6219602
[TBL] [Abstract][Full Text] [Related]
14. Brain glucose utilization in childhood Huntington's disease studied with positron emission tomography (PET).
De Volder A; Bol A; Michel C; Cogneau M; Evrard P; Lyon G; Goffinet AM
Brain Dev; 1988; 10(1):47-50. PubMed ID: 2967038
[TBL] [Abstract][Full Text] [Related]
15. Identification of frontal lobe epileptic foci in children using positron emission tomography.
da Silva EA; Chugani DC; Muzik O; Chugani HT
Epilepsia; 1997 Nov; 38(11):1198-208. PubMed ID: 9579921
[TBL] [Abstract][Full Text] [Related]
16. Glucose Metabolic Profile by Visual Assessment Combined with Statistical Parametric Mapping Analysis in Pediatric Patients with Epilepsy.
Zhu Y; Feng J; Wu S; Hou H; Ji J; Zhang K; Chen Q; Chen L; Cheng H; Gao L; Chen Z; Zhang H; Tian M
J Nucl Med; 2017 Aug; 58(8):1293-1299. PubMed ID: 28104740
[TBL] [Abstract][Full Text] [Related]
17. Relative glucose metabolic rate higher in white matter in patients with schizophrenia.
Buchsbaum MS; Buchsbaum BR; Hazlett EA; Haznedar MM; Newmark R; Tang CY; Hof PR
Am J Psychiatry; 2007 Jul; 164(7):1072-81. PubMed ID: 17606659
[TBL] [Abstract][Full Text] [Related]
18. Topography of brain glucose hypometabolism and epileptic network in glucose transporter 1 deficiency.
Akman CI; Provenzano F; Wang D; Engelstad K; Hinton V; Yu J; Tikofsky R; Ichese M; De Vivo DC
Epilepsy Res; 2015 Feb; 110():206-15. PubMed ID: 25616474
[TBL] [Abstract][Full Text] [Related]
19. Regional kinetic constants and cerebral metabolic rate for glucose in normal human volunteers determined by dynamic positron emission tomography of [18F]-2-fluoro-2-deoxy-D-glucose.
Heiss WD; Pawlik G; Herholz K; Wagner R; Göldner H; Wienhard K
J Cereb Blood Flow Metab; 1984 Jun; 4(2):212-23. PubMed ID: 6609929
[TBL] [Abstract][Full Text] [Related]
20. Mesiobasal versus lateral temporal lobe epilepsy: metabolic differences in the temporal lobe shown by interictal 18F-FDG positron emission tomography.
Hajek M; Antonini A; Leenders KL; Wieser HG
Neurology; 1993 Jan; 43(1):79-86. PubMed ID: 8423915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
